[1] Peters GL. Migraine overview and summary of current and emerging treatment options[J]. Am J Manag Care, 2019, 25(2 Suppl):23-34. [2] Head and Facial Pain Group, Pain Branch, Chinese Medical Association; Pain and Sensory Disorder Special Committee, Neurology Branch, Chinese Medical Doctor Association. Guidelines for prevention and treatment of migraine in China[J]. Zhongguo Teng Tong Yi Xue Za Zhi, 2016, 22:721-727[.中华医学会疼痛学分会头面痛学组, 中国医师协会神经内科医师分会疼痛和感觉障碍专委会. 中国偏头痛防治指南[J]. 中国疼痛医学杂志, 2016, 22:721-727.] [3] Gray PA, Burtness HI. Hypoglycemic headache[J]. Endocrinology, 1935, 19:549-560. [4] Amery WK. Brain hypoxia:the turning-point in the genesis of the migraine attack[J]? Cephalalgia, 1982, 2:83-109. [5] Gross EC, Lisicki M, Fischer D, Sándor PS, Schoenen J. The metabolic face of migraine:from pathophysiology to treatment[J]. Nat Rev Neurol, 2019, 15:627-643. [6] Szabo E, Green S, Karunakaran KD, Sieberg CB, Elman I, Burstein R, Borsook D. Migraine:interactions between brain's trait and state[J]. CNS Spectr, 2021, 21:1-9. [7] Sangiorgi S, Mochi M, Riva R, Cortelli P, Monari L, Pierangeli G, Montagna P. Abnormal platelet mitochondrial function in patients affected by migraine with and without aura[J]. Cephalalgia, 1994, 14:21-23. [8] Borkum JM. Brain energy deficit as a source of oxidative stress in migraine:a molecular basis for migraine susceptibility[J]. Neurochem Res, 2021, 46:1913-1932. [9] Togha M, Razeghi Jahromi S, Ghorbani Z, Ghaemi A, Rafiee P. An investigation of oxidant/antioxidant balance in patients with migraine:a case-control study[J]. BMC Neurol, 2019, 19:323. [10] Fila M, Chojnacki C, Chojnacki J, Blasiak J. Nutrients to improve mitochondrial function to reduce brain energy deficit and oxidative stress in migraine[J]. Nutrients, 2021, 13:4433. [11] Lisicki M, D'Ostilio K, Coppola G, Scholtes F, Maertens de Noordhout A, Parisi V, Schoenen J, Magis D. Evidence of an increased neuronal activation-to-resting glucose uptake ratio in the visual cortex of migraine patients:a study comparing 18FDG-PET and visual evoked potentials[J]. J Headache Pain, 2018, 19:49. [12] Zhang DG, Amin FM, Guo S, Vestergaard MB, Hougaard A, Ashina M. Plasma glucose levels increase during spontaneous attacks of migraine with and without aura[J]. Headache, 2020, 60:655-664. [13] Shaw SW, Johnson RH, Keogh HJ. Metabolic changes during glucose tolerance tests in migraine attacks[J]. J Neurol Sci, 1977, 33:51-59. [14] De Silva KL, Ron MA, Pearce J. Blood sugar response to glucagon in migraine[J]. J Neurol Neurosurg Psychiatry, 1974, 37:105-107. [15] Sándor PS, Dydak U, Schoenen J, Kollias SS, Hess K, Boesiger P, Agosti RM. MR-spectroscopic imaging during visual stimulation in subgroups of migraine with aura[J]. Cephalalgia, 2005, 25:507-518. [16] Maier JA, Pickering G, Giacomoni E, Cazzaniga A, Pellegrino P. Headaches and magnesium:mechanisms, bioavailability, therapeutic efficacy and potential advantage of magnesium pidolate[J]. Nutrients, 2020, 12:2660. [17] Ebahimzadeh K, Gholipour M, Samadian M, Taheri M, Ghafouri-Fard S. A comprehensive review on the role of genetic factors in the pathogenesis of migraine[J]. J Mol Neurosci, 2021, 71:1987-2006. [18] Guo S, Esserlind AL, Andersson Z, Frederiksen AL, Olesen J, Vissing J, Ashina M. Prevalence of migraine in persons with the 3243A > G mutation in mitochondrial DNA[J]. Eur J Neurol, 2016, 23:175-181. [19] Hou Y, Zhao XT, Xie ZY, Yuan Y, Wang ZX. Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes/myoclonus epilepsy with ragged-red fibers/leigh overlap syndrome caused by mitochondrial DNA 8344A > G mutation[J]. Beijing Da Xue Xue Bao Yi Xue Ban, 2020, 52:851-855. [20] Zaki EA, Freilinger T, Klopstock T, Baldwin EE, Heisner KR, Adams K, Dichgans M, Wagler S, Boles RG. Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome[J]. Cephalalgia, 2009, 29:719-728. [21] Rainero I, Vacca A, Govone F, Gai A, Pinessi L, Rubino E. Migraine:genetic variants and clinical phenotypes[J]. Curr Med Chem, 2019, 26:6207-6221. [22] Liu L, Yu Y, He J, Guo L, Li H, Teng J. Effects of MTHFR C677T and A1298C polymorphisms on migraine susceptibility:a meta-analysis of 26 studies[J]. Headache, 2019, 59:891-905. [23] Yamanaka G, Suzuki S, Morishita N, Takeshita M, Kanou K, Takamatsu T, Morichi S, Ishida Y, Watanabe Y, Go S, Oana S, Kawashima H. Experimental and clinical evidence of the effectiveness of riboflavin on migraines[J]. Nutrients, 2021, 13:2612. [24] Dahri M, Tarighat-Esfanjani A, Asghari-Jafarabadi M, Hashemilar M. Oral coenzyme Q10 supplementation in patients with migraine:effects on clinical features and inflammatory markers[J]. Nutr Neurosci, 2019, 22:607-615. [25] Hajihashemi P, Askari G, Khorvash F, Reza Maracy M, Nourian M. The effects of concurrent coenzyme Q10, L-carnitine supplementation in migraine prophylaxis:a randomized, placebo-controlled, double-blind trial[J]. Cephalalgia, 2019, 39:648-654. [26] Karimi N, Razian A, Heidari M. The efficacy of magnesium oxide and sodium valproate in prevention of migraine headache:a randomized, controlled, double-blind, crossover study[J]. Acta Neurol Belg, 2021, 121:167-173. [27] Di Lorenzo C, Pinto A, Ienca R, Coppola G, Sirianni G, Di Lorenzo G, Parisi V, Serrao M, Spagnoli A, Vestri A, Schoenen J, Donini LM, Pierelli F. A randomized double-blind, cross-over trial of very low-calorie diet in overweight migraine patients:a possible role for ketones[J]? Nutrients, 2019, 11:1742. [28] Haanes KA, Edvinsson L. Pathophysiological mechanisms in migraine and the identification of new therapeutic targets[J]. CNS Drugs, 2019, 33:525-537. [29] Grech O, Mollan SP, Wakerley BR, Fulton D, Lavery GG, Sinclair AJ. The role of metabolism in migraine pathophysiology and susceptibility[J]. Life (Basel), 2021, 11:415. [30] Gross EC, Klement RJ, Schoenen J, D'Agostino DP, Fischer D. Potential protective mechanisms of ketone bodies in migraine prevention[J]. Nutrients, 2019, 11:811. [31] De Luca C, Baldacci F, Mazzucchi S, Lombardo I, Curto L, Ulivi M, Chico L, Papa M, Siciliano G, Gori S. CGRP inhibitors and oxidative stress biomarkers in resistant migraine:a real-life study with erenumab, fremanezumab, and galcanezumab[J]. J Clin Med, 2021, 10:4586. [32] Hu SH, Guang Y, Wang WX. Protective effects of calcitonin gene-related peptide-mediated p38 mitogen-activated protein kinase pathway on severe acute pancreatitis in rats[J]. Dig Dis Sci, 2019, 64:447-455. [33] Dong X, Guan X, Chen K, Jin S, Wang C, Yan L, Shi Z, Zhang X, Chen L, Wan Q. Abnormal mitochondrial dynamics and impaired mitochondrial biogenesis in trigeminal ganglion neurons in a rat model of migraine[J]. Neurosci Lett, 2017, 636:127-133. |